IDEXX Laboratories, Inc. (BMV:IDXX)

IDEXX Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	4,304	3,898	3,661	3,367	3,215
Revenue Growth (YoY)	10.42%	6.46%	8.72%	4.73%	18.80%
Cost of Revenue	1,644	1,519	1,471	1,363	1,326
Gross Profit	2,660	2,379	2,190	2,004	1,889
Selling, General & Admin	1,048	1,031	901.89	850.75	796.4
Research & Development	251.21	219.79	190.95	254.82	161.01
Operating Income	1,360	1,128	1,097	898.77	932.03
Interest Income	3.01	12.7	5.63	1.07	0.43
Interest Expense	-38.85	-31.21	-41.58	-39.86	-29.81
Total Non-Operating Income (Expense)	-35.84	-18.51	-35.95	-38.79	-29.37
Pretax Income	1,324	1,110	1,061	859.97	902.65
Provision for Income Taxes	264.73	221.96	216.13	180.88	157.81
Net Income	1,059	887.87	845.04	679.09	744.85
Minority Interest in Earnings	-	-	-	-	-0
Net Income to Common	1,059	887.87	845.04	679.09	744.85
Net Income Growth	19.33%	5.07%	24.44%	-8.83%	28.03%
Shares Outstanding (Basic)	80	82	83	84	85
Shares Outstanding (Diluted)	81	83	84	85	87
Shares Change (YoY)	-2.67%	-0.87%	-0.73%	-2.28%	-0.17%
EPS (Basic)	13.17	10.77	10.17	8.12	8.74
EPS (Diluted)	13.08	10.67	10.06	8.03	8.60
EPS Growth	22.59%	6.06%	25.28%	-6.63%	28.17%
Free Cash Flow	1,057	808.08	772.88	394.15	636
Free Cash Flow Growth	30.82%	4.55%	96.09%	-38.03%	17.54%
Free Cash Flow Per Share	13.05	9.71	9.20	4.66	7.35
Gross Margin	61.80%	61.04%	59.82%	59.52%	58.76%
Operating Margin	31.60%	28.95%	29.97%	26.69%	28.99%
Profit Margin	24.62%	22.78%	23.08%	20.17%	23.17%
FCF Margin	24.56%	20.73%	21.11%	11.71%	19.78%
EBITDA	1,505	1,258	1,212	1,011	1,037
EBITDA Margin	34.97%	32.28%	33.11%	30.01%	32.24%
EBIT	1,360	1,128	1,097	898.77	932.03
EBIT Margin	31.60%	28.95%	29.97%	26.69%	28.99%
Effective Tax Rate	19.99%	20.00%	20.37%	21.03%	17.48%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.